Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade

Clicks: 718
ID: 113731
2011
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The peroxiredoxin (PRX) family of antioxidant enzymes helps maintain the intracellular reducing milieu and suppresses apoptosis in non-neuronal cells. However, whether PRX can inhibit neuronal apoptosis through specific signaling mechanisms remains poorly understood. Induction of PRX2, the most abun …
Reference Key
x2011theperoxiredoxin-2 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hu X;Weng Z;Chu CT;Zhang L;Cao G;Gao Y;Signore A;Zhu J;Hastings T;Greenamyre JT;Chen J;;
Journal The Journal of neuroscience : the official journal of the Society for Neuroscience
Year 2011
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/21209210
Keywords
Tumor National Center for Biotechnology Information NCBI NLM MEDLINE Mice Inbred C57BL RNA animals humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male N.I.H. Extramural Disease Models Animal aged middle aged 80 and over cell line Cell Differentiation / drug effects gene expression regulation / drug effects enzyme inhibitors / pharmacology brain / drug effects brain / metabolism analysis of variance signal transduction / drug effects* cell survival / drug effects gene expression regulation / genetics pmid:21209210 pmc3078571 doi:10.1523/jneurosci.4589-10.2011 xiaoming hu zhongfang weng jun chen apomorphine brain / pathology cytochromes / pharmacology dopamine / metabolism* green fluorescent proteins / genetics indoles map kinase kinase kinase 5 / drug effects* motor activity / drug effects neurodegenerative diseases / chemically induced neurodegenerative diseases / prevention & control* neuroprostanes / therapeutic use* oxidopamine / adverse effects parkinson disease / metabolism parkinson disease / pathology peroxiredoxins / therapeutic use* postmortem changes small interfering / metabolism thioredoxins / pharmacology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.